Validation of “SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade” in an independent cohort of 4,407 patients

Cancer Letters 2026

View at publisher
Authors: Ronen Arbel, Lior Rokach, Talish Razi, Tamar Tadmor
DOI: 10.1016/j.canlet.2026.218319
Cited by: 2
References: 5

Fields of Study & Subjects

COVID-19 and healthcare impacts SARS-CoV-2 and COVID-19 Research Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Cancer Letters
Publisher
Elsevier BV
Volume
643
Pages
218319–218319
Publication date
12 February 2026
Language
EN